Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Cancer. 2013 Aug 6;119(21):10.1002/cncr.28295. doi: 10.1002/cncr.28295

Figure 3.

Figure 3

A. Kaplan-Meier analysis of cancer-specific survival at two years for patients with locoregional pancreatic adenocarcinoma and EUS. EUS group had improved survival (25.4% vs. 16.4%, p<.0001).

B. Kaplan-Meier analysis of non-cancer survival at two years for patients with locoregional pancreatic adenocarcinoma and EUS. EUS group had improved survival (85.3% vs. 78.4%, p<.0001)